Results 291 to 300 of about 680,317 (306)

Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis

New England Journal of Medicine, 2002
Bruce D Trapp, Richard A. Rudick, Ansi Chang   +2 more
exaly  

Hepatoportal Sclerosis

Seminars in Liver Disease, 1995
P, Bioulac-Sage, B, Le Bail, P H, Bernard, C, Balabaud   +3 more
openaire   +2 more sources

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event

New England Journal of Medicine, 2003
Hanno Ulmer, Markus Reindl
exaly  

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

New England Journal of Medicine, 2012
Robert J. Fox, Vissia Viglietta, Michael Hutchinson   +2 more
exaly  

Tuberous Sclerosis

Archives of Ophthalmology, 1992
openaire   +2 more sources

Multiple Sclerosis

New England Journal of Medicine, 1982
Henry F McFarland, Dale E McFarlin, D E McFarlin   +2 more
exaly  

MÖNCKEBERG’S SCLEROSIS

Acta Clinica Belgica, 2010
C W, Tsai, C C, Kuo, J J, Hwang
openaire   +2 more sources

Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis

JAMA - Journal of the American Medical Association, 2006
Kassandra L Munger, Alberto Ascherio, Bruce Hollis   +2 more
exaly  

Multiple Sclerosis

Physical Therapy, 1957
openaire   +2 more sources

Tuberous Sclerosis

Archives of Neurology, 1970
R. H. Wilkins, I. A. Brody
openaire   +2 more sources